Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Focetria H1N1 Vaccine in Healthy Adults
NCT01079273Phase 4Completed
- Sponsor
- Opera CRO
- Start
- Dec 2009
- Primary completion
- Nov 2010
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in Influenza A Virus H1N1 Subtype Infection (H1N1), sponsored by Opera CRO. Started Dec 2009; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
Influenza A Virus H1N1 Subtype Infection (H1N1)
Beyond the preview
Go deeper on NCT01079273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01079273.